|
Measurement science of the androgen receptor splice variant-7 protein in primary and castration-resistant prostate cancer tissue. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Aventis Pharma (Inst); Bayer (Inst); Janssen Diagnostics (Inst) |
Travel, Accommodations, Expenses - Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Sanofi |
Patents, Royalties, Other Intellectual Property - License to NKT Therapeutics for an antibody |
Expert Testimony - Astellas Medivation |
Travel, Accommodations, Expenses - Janssen |
|
|
No Relationships to Disclose |
|
|
Honoraria - Gilead Sciences; Sanofi |
Consulting or Advisory Role - Janssen Oncology; Sun Pharma; Tokai Pharmaceuticals |
Research Funding - Astellas Pharma (Inst); Gilead Sciences (Inst); Mirati Therapeutics (Inst); Orion (Inst); Sanofi (Inst) |
Patents, Royalties, Other Intellectual Property - Jun Luo is a co-inventor of a technology assigned to Johns Hopkins University who licensed to Tokai Pharmaceuticals. (Inst); Jun Luo is a co-inventor of a technology licensed to Qiagen (Inst) |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Pfizer; Sanofi |
Research Funding - AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst) |
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); PARP inhibitors and DNA repair defects (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex |